SCHEMBL4926767

SCHEMBL4926767

CCC(C)Nc1cccc(COc2c(Cl)cc(CCC(=O)O)cc2Cl)c1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 12/20 0.44
THRB P10828 12/20 0.44
FFAR4 Q5NUL3 5/20 0.41
FFAR1 O14842 2/20 0.41
ESR1 P03372 1/20 0.39
NR3C1 P04150 1/20 0.39
PGR P06401 1/20 0.39
NR3C2 P08235 1/20 0.39
AR P10275 1/20 0.39
S1PR1 P21453 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.38
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
ABL1 P00519 1/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4931064 0.91 THRA (0.47) THRATHRBFFAR4FFAR1ESR1
SCHEMBL4931323 0.90 THRA (0.57) THRATHRBFFAR4FFAR1ESR1
SCHEMBL4933659 0.90 THRA (0.46) THRATHRBFFAR4FFAR1ESR1
SCHEMBL4924452 0.87 THRA (0.39) THRATHRBFFAR4FFAR1
SCHEMBL4931430 0.86 THRA (0.40) THRATHRBFFAR4FFAR1MEN1
SCHEMBL5105563 0.86 THRA (0.46) THRATHRBFFAR4FFAR1ESR1
SCHEMBL4928696 0.86 THRA (0.51) THRATHRBFFAR4FFAR1ESR1
SCHEMBL4931277 0.86 THRA (0.49) THRATHRBFFAR4FFAR1ESR1
SCHEMBL4928683 0.84 THRA (0.46) THRATHRBFFAR4FFAR1ESR1
SCHEMBL5109561 0.84 THRA (0.46) THRATHRBFFAR4FFAR1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA THRA 3/4885THRB 4/4885FFAR4 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.